Tải xuống
Tóm tắt
Objectves:
1) To study signs and symptom of high risk gestational trophoblastic neoplasms
2) Role of multi-agents chemotherapy in treatment of high-risk patients.
Methods: A perspective study.
Materials: 25 patients who had high-risk gestational trophoblastic neoplasms were treated in department of Obstetrics and Gynecology, Hue Central Hospital.
Results: Mean age of patients was 28.3±7.5, risk-score was 8.6±0.8, number of cycles of chemotherapy was 8.3±3.4, rate of success of the regimen was 96%, only 28% of patients had total hysterectomy, 100% of patients had side-effects, of that the most common was hair-loss. 12 pateints were pregnant after treatment, 41.7% of them reached term pregnancy.
Conclusion: Multi-agents chemotherapy with EM/CO regimen is safe and effective in treatment of high- risk gestaional trophoblastic neopalsia.
Tài liệu tham khảo
Kajlana A, Ava D, Shilpa R, Anila K, Sonali G, Kolhaple U (2007), “High risk gestational trophoblastic tumor”, J Obstet Gynecol India, 7(3):221-226.
Deep JP, Sedhai LB, Napit J, Pariyar J (2013), “Gestational trophoblastic disease”, Journal of Chitwan Medical College, 3(4):4-11.
Dobson LS, Lrigian PC, Coleman RE, Hancock BW (2000), “Persistent gestational trophoblastic disease: results with MAC (methotrexate, etoposide and actinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and actinomycin) as second-line therapy for low risk disease”, British Journal of Cancer, 82(7):1547-1552.
Escobar PF, Lurain JR, Singh DK, Bozorgi K, Fishman DA (2003), “Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy”, Gynecologic Oncology, 91:552-557.
Osborne RJ, Ath Hion, Bessette P, Gerulath AH, Jolicoeur L, Savoie R (2002), “Gestational trophoblastic disease, a good clinical practice guidelines”, Number 14.
Ghaemmaghami F, Sorbihravand F, Ayatollahi H, Modarres M (2005), “Successful treatment of gestational trophoblastic neoplasm metastatic to the colon: Case report”, Cancer Therapy, 3:551-554.
Hanna RK, Soper JT (2010), “The Role of Surgery and Radiation Therapy in the Management of Gestational Trophoblastic Disease”, The Oncologist, 15:593-600.
Hemida RAE, Toson B, Shalaby H, Refake M, Shahin ES (2011), “Chemo-resistant gestational trophoblastic neoplasia, 5-years experience of Mansoura University Hospital, Egypt”, Open Journal of Obstetrics and Gynecology, 1:153-157.
Ilancheran A (1998), “Optimal Treatment in Gestational Trophoblastic Disease”, Ann Acad Med Singapore, 27:698-704.
Jones WB, Cardinale C, Lewis JL (1997), “Management of high-risk gestational trophoblastic disease - Memorial Hospital experience”, Int J Gynecol Cancer, 7:27-33.
Kim JH, Park DC, Bae SN, Namkoong SE, Kim SJ (1998), “Subsequent Reproductive Experience after Treatment for Gestational Trophoblastic Disease”, GYNECOLOGIC ONCOLOGY, 71:108-112.
Kim SJ, Bae SN, Kim JH, Kim CJ, Jung JK (1998), “Risk Factors for the Prediction of Treatment Failure in Gestational Trophoblastic Tumors Treated with EMA/CO Regimen”, GYNECOLOGIC ONCOLOGY, 71:247-253.
Lurain JR (2010), “The role of surgery in the management of high-risk gestational trophoblastic neoplasia”, Cytoreductive Surgery in Gynecologic Oncology: A Multidisciplinary Approach, 2010: 153-160.
Maria A, El-Shebiniy M, Sadaka E, Ramadan M (2012), “Treatment Outcome of Gestational Trophoblastic Neoplasia”, Journal of American Science, 8(11):261-267.
Matsui H, Iitsuka Y, Suzuka K, Yamazawa K, Sekei K, Sekiya S (2002), “Outcome of subsequent pregnancy after treatment for persistent gestational trophoblastic tumor”, Human Reproduction, 17:469-472.
May T, Goldstein DP, Berkowitz RS (2011), “Current management of gestational trophoblastic neoplasia”, Hematology Oncology and Stem Cell Research, 2011:1-12.
Ngan HYS, Kohorn EI, Cole LA, Kurman RJ, Kim SJ, Lurain JR, Seckl MJ, Sasaki S, Soper JT (2012), “Trophoblastic disease”, International Journal of Gynecology and Obstetrics, 119S2(2012): S130-S136.
Ngan HYS, Michael J, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR (2015), “Update on the diagnosis and management of gestational trophoblastic disease”, International Journal of Gynecology and Obstetrics, 131(2015): S123-S126.
Priyanka KK, Pariseeam DS (2015), “High risk gestational trophoblastic diseases: Diagnosis and primary management with EMA/CO chemotherapy”, Asian Pac J. Health Sci, 2(4):82-86.
Soper JT (2006), “Gestational Trophoblastic Disease: An Overview”, Obstet Gynecol, 108:176-187.
| Đã xuất bản | 19-08-2016 | |
| Toàn văn |
|
|
| Ngôn ngữ |
|
|
| Số tạp chí | Số 36 (2016) | |
| Phân mục | Nghiên cứu | |
| DOI | ||
| Từ khóa | High-risk gestational trophoblastic neoplasms, EM/CO, pregnancy |
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .
Bản quyền (c) 2025 Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế